Disparities in human papillomavirus (HPV) vaccine initiation and completion based on sexual orientation among women in the United States

References

• Centers for disease control and prevention. Human Papillomavirus (HPV). Accessed 5 January 2019. https://www.cdc.gov/hpv/parents/about-hpv.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fhpv%2Fparents%2Fwhatishpv.html.
   Google Scholar
• Chesson HW, Dunne EF, Hariri S, Markowitz LE. The estimated lifetime probability of acquiring human papillomavirus in the United States. Sex Transm Dis. 2014;41(11):660–64. doi:10.1097/OLQ.0000000000000193.
   PubMed Web of Science ®Google Scholar
• Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, Ocfemia MCB, Su J, Xu F, Weinstock H. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis. 2013;40(3):187–93. doi:10.1097/OLQ.0b013e318286bb53.
   PubMed Web of Science ®Google Scholar
• Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer. 2008;113(10 Suppl):3036–46. doi:10.1002/cncr.23764.
   PubMed Web of Science ®Google Scholar
• Dunne EF, Markowitz LE, Saraiya M, Stokley S, Middleman a, Unger ER, Williams a, Iskander J. CDC grand rounds: reducing the burden of HPV-associated cancer and disease. MMWR Morb Mortal Wkly Rep. 2014;63:69–72.
   PubMed Web of Science ®Google Scholar
• Stier EA, Chigurupati NL, Fung L. Prophylactic HPV vaccination and anal cancer. Hum Vaccin Immunother. 2016;12(6):1348–51. doi:10.1080/21645515.2016.1149274.
   PubMed Web of Science ®Google Scholar
• Adjei Boakye E, Buchanan P, Hinyard L, Osazuwa-Peters N, Schootman M, Piccirillo JF. Incidence and risk of second primary malignant neoplasm after a first head and neck squamous cell carcinoma. JAMA Otolaryngol– Head Neck Surg. 2018;144(8):727–37. doi:10.1001/jamaoto.2018.0993.
   Google Scholar
• Suk R, Mahale P, Sonawane K, Sikora AG, Chhatwal J, Schmeler KM, Sigel K, Cantor SB, Chiao EY, Deshmukh AA, et al. Trends in risks for second primary cancers associated with index human papillomavirus–associated cancers. JAMA Network Open. 2018;1(5):e181999. doi:10.1001/jamanetworkopen.2018.1999.
   PubMed Web of Science ®Google Scholar
• Wang M, Sharma a, Osazuwa-Peters N, Simpson MC, Schootman M, Piccirillo JF, Huh WK, Adjei Boakye E. Risk of subsequent malignant neoplasms after an index potentially-human papillomavirus (HPV)-associated cancers. Cancer Epidemiol. 2020;64:101649. doi:10.1016/j.canep.2019.101649.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Cancers associated with human papillomavirus, United States—2012–2016. Accessed 5 Feb 2020. https://www.cdc.gov/cancer/uscs/about/data-briefs/no10-hpv-assoc-cancers-UnitedStates-2012-2016.htm.
   Google Scholar
• Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2019;68(32):698–702. doi:10.15585/mmwr.mm6832a3.
   PubMed Web of Science ®Google Scholar
• Arbyn M, Xu L. Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials. Expert Rev Vaccines. 2018;17(12):1085–91. doi:10.1080/14760584.2018.1548282.
   PubMed Web of Science ®Google Scholar
• Walker TY, Elam-Evans LD, Yankey D, Markowitz LE, Williams CL, Mbaeyi SA, Fredua B, Stokley S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 Years – United States, 2017. MMWR Morb Mortal Wkly Rep. 2018;67(33):909–17. doi:10.15585/mmwr.mm6733a1.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services. 2020 topics and objectives: immunization and infectious diseases objectives. Accessed May 20, 2017. http://www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases/objectives?topicId=23.
   Google Scholar
• Adjei Boakye E, Lew D, Muthukrishnan M, Tobo BB, Rohde RL, Varvares MA, Osazuwa-Peters N. Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18-26 year olds in the United States. Hum Vaccin Immunother. 2018;14(8):2016–24. doi:10.1080/21645515.2018.1467203.
   PubMed Web of Science ®Google Scholar
• Srivastav a, O’Halloran a, Lu P-J, Williams WW, Hutchins SS. Vaccination differences among U.S. adults by their self-identified sexual orientation, National Health Interview Survey, 2013-2015. PLoS One. 2019;14(3):e0213431. doi:10.1371/journal.pone.0213431.
   PubMed Web of Science ®Google Scholar
• Lindley LL, Walsemann KM, Carter JW Jr. Invisible and at risk: sTDs among young adult sexual minority women in the United States. Perspect Sex Reprod Health. 2013;45(2):66–73. doi:10.1363/4506613.
   PubMed Web of Science ®Google Scholar
• Marrazzo JM, Gorgos LM. Emerging sexual health issues among women who have sex with women. Current Infect Dis Reports. 2012;14(2):204–211.
   Web of Science ®Google Scholar
• Gorgos LM, Marrazzo JM. Sexually transmitted infections among women who have sex with women. Clin Infect Dis. 2011;53(Suppl 3):S84–91. doi:10.1093/cid/cir697.
   PubMedGoogle Scholar
• Marrazzo JM, Coffey P, Bingham a. Sexual practices, risk perception and knowledge of sexually transmitted disease risk among lesbian and bisexual women. Perspect Sex Reprod Health. 2005;37(1):6–12. doi:10.1363/3700605.
   PubMed Web of Science ®Google Scholar
• Dinh TH, Sternberg M, Dunne EF, Markowitz LE. Genital warts among 18- to 59-year-olds in the United States, national health and nutrition examination survey, 1999–2004. Sex Transm Dis. 2008;35(4):357–60. doi:10.1097/OLQ.0b013e3181632d61.
   PubMed Web of Science ®Google Scholar
• Agenor M, Krieger N, Austin SB, Haneuse S, Gottlieb BR. Sexual orientation disparities in Papanicolaou test use among US women: the role of sexual and reproductive health services. Am J Public Health. 2014;104(2):e68–73. doi:10.2105/AJPH.2013.301548.
   PubMed Web of Science ®Google Scholar
• Charlton BM, Corliss HL, Missmer SA, Frazier AL, Rosario M, Kahn JA, Austin SB. Reproductive health screening disparities and sexual orientation in a cohort study of U.S. adolescent and young adult females. J Adolesc Health. 2011;49(5):505–10. doi:10.1016/j.jadohealth.2011.03.013.
   PubMed Web of Science ®Google Scholar
• McCauley HL, Silverman JG, Decker MR, Agénor M, Borrero S, Tancredi DJ, Zelazny S, Miller E. Sexual and reproductive health indicators and intimate partner violence victimization among female family planning clinic patients who have sex with women and men. J Women’s Health (2002). 2015;24(8):621–28. doi:10.1089/jwh.2014.5032.
   PubMed Web of Science ®Google Scholar
• Coker AL, Hopenhayn C, DeSimone CP, Bush HM, Crofford L. Violence against women raises risk of cervical cancer. J Women’s Health (2002). 2009;18(8):1179–85. doi:10.1089/jwh.2008.1048.
   PubMed Web of Science ®Google Scholar
• Centers for disease control and prevention. NHANES response rates and CPS totals; 2016. Accessed July 19 2016. http://www.cdc.gov/nchs/nhanes/response_rates_CPS.htm.
   Google Scholar
• Centers for disease control prevention (CDC). National health and nutrition examination survey. Accessed August 13, 2017. https://www.cdc.gov/nchs/nhanes/index.htm.
   Google Scholar
• Agénor M, McCauley HL, Peitzmeier SM, Haneuse S, Gordon AR, Potter J, Austin SB. Sex of sexual partners and human papillomavirus vaccination among U.S. girls and women. Am J Prev Med. 2016;50(3):318–27. doi:10.1016/j.amepre.2015.08.025.
   PubMed Web of Science ®Google Scholar
• Agenor M, Peitzmeier S, Gordon AR, Haneuse S, Potter JE, Austin SB. Sexual orientation identity disparities in awareness and initiation of the human papillomavirus vaccine among U.S. women and girls: a national survey. Ann Intern Med. 2015;163(2):99–106. doi:10.7326/M14-2108.
   PubMed Web of Science ®Google Scholar
• Griggs J, Maingi S, Blinder V, Denduluri N, Khorana AA, Norton L, Francisco M, Wollins DS, Rowland JH. American Society of Clinical Oncology position statement: strategies for reducing cancer health disparities among sexual and gender minority populations. J Clin Oncol. 2017;35(19):2203. doi:10.1200/JCO.2016.72.0441.
   PubMed Web of Science ®Google Scholar
• National Institutes of Health. Sexual and Gender Minorities Formally Designated as a Health Disparity Population for Research Purposes. Director’s Message Web site. Published 2016. https://www.nimhd.nih.gov/about/directors-corner/messages/message_10-06-16.html.
   Google Scholar
• McRee AL, Katz ML, Paskett ED, Reiter PL. HPV vaccination among lesbian and bisexual women: findings from a national survey of young adults. Vaccine. 2014;32(37):4736–42. doi:10.1016/j.vaccine.2014.07.001.
   PubMed Web of Science ®Google Scholar
• Tornello SL, Riskind RG, Patterson CJ. Sexual orientation and sexual and reproductive health among adolescent young women in the United States. J Adolesc Health. 2014;54(2):160–68. doi:10.1016/j.jadohealth.2013.08.018.
   PubMed Web of Science ®Google Scholar
• Reiter PL, McRee AL, Katz ML, Paskett ED. Human papillomavirus vaccination among young adult gay and bisexual men in the United States. Am J Public Health. 2015;105(1):96–102. doi:10.2105/AJPH.2014.302095.
   PubMed Web of Science ®Google Scholar
• Osazuwa-Peters N. Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States--do we need a broader vaccine policy? Vaccine. 2013;31(47):5500-5505. doi:10.1016/j.vaccine.2013.09.031
   PubMed Web of Science ®Google Scholar
• Mohammed KA, Geneus CJ, Osazuwa-Peters N, Adjei Boakye E, Tobo BB, Burroughs TE. Disparities in provider recommendation of human papillomavirus vaccination for U.S. adolescents. J Adolesc Health. 2016;59(5):592–98. doi:10.1016/j.jadohealth.2016.06.005.
   PubMed Web of Science ®Google Scholar
• Lipton BJ, Decker SL. ACA provisions associated with increase in percentage of young adult women initiating and completing the HPV vaccine. Health Affairs (Project Hope). 2015;34(5):757–64. doi:10.1377/hlthaff.2014.1302.
   PubMed Web of Science ®Google Scholar
• Sonawane K, Nyitray AG, Nemutlu GS, Swartz MD, Chhatwal J, Deshmukh AA. Prevalence of human papillomavirus infection by number of vaccine doses among US women. JAMA Netw Open. 2019;2(12):e1918571. doi:10.1001/jamanetworkopen.2019.18571.
   PubMed Web of Science ®Google Scholar
• Kreimer AR, Herrero R, Sampson JN, Porras C, Lowy DR, Schiller JT, Schiffman M, Rodriguez AC, Chanock S, Jimenez S, et al. Evidence for single-dose protection by the bivalent HPV vaccine – review of the Costa Rica HPV vaccine trial and future research studies. Vaccine. 2018;36(32Pt a):4774–82. doi:10.1016/j.vaccine.2017.12.078.
   PubMedGoogle Scholar
• Adjei Boakye E, Tobo BB, Osazuwa-Peters N, Mohammed KA, Geneus CJ, Schootman M. A comparison of parent- and provider-reported human papillomavirus vaccination of adolescents. Am J Prev Med. 2017;52(6):742–52. doi:10.1016/j.amepre.2016.10.016.
   PubMed Web of Science ®Google Scholar